Cochrane Hypertension

04/22/2026

🚨ICYMI: Cochrane Hypertension Review update

Pharmacotherapy for mild https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006742.pub3/full

In ppl w/ mildly elevated (BP) w/out cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD

Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in About Cookies.

04/22/2026

🚨ICYMI: Cochrane review:

supplements for blood pressure lowering in adults
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015464.pub2/full

🤔 Very uncertain evidence for effect of riboflavin on
🎯 Large, well‐conducted trials needed

03/02/2026

🚨ICYMI - Updated Cochrane :

Withdrawal of antihypertensive drugs in older people 💊
https://doi.org/10.1002/14651858.CD012572.pub3

"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"

12/24/2025

🆕 Cochrane review:

supplements for blood pressure lowering in adults
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015464.pub2/full

🤔 Very uncertain evidence for effect of riboflavin on
🎯 Large, well‐conducted trials needed for higher-certainty evidence

09/25/2025

🆕Review update🆕

Pharmacotherapy for mild https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006742.pub3/full

In people with mildly elevated (BP) without cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD

09/02/2025

ICYMI - Cochrane 🎺

Renin inhibitors versus angiotensin receptor blockers for primary
https://doi.org/10.1002/14651858.CD012570.pub2

04/21/2025

🆕 We've published a new Cochrane protocol:

Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists
https://doi.org/10.1002/14651858.CD016144

04/11/2025

🚨Updated Cochrane :

Withdrawal of antihypertensive drugs in older people 💊
https://doi.org/10.1002/14651858.CD012572.pub3

"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"



The Cochrane Library Cochrane Canada Cochrane New Zealand

04/01/2025

🆕 Cochrane 🆕

Effect of adrenergic agonist oral on blood pressure:
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007895.pub3/full

03/31/2025

🆕 Cochrane 🆕

Effect of on blood pressure:
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007896.pub4

03/04/2025

webinar recording

Debunking some of the hype in
ti.ubc.ca/drugevidence24

Dr. James Wright summarizes latest evidence on :

⏰ chronotherapy
💊 first line tx
🎯 blood pressure targets
⚠️ treatment efficacy + safety

03/04/2025

🆕Cochrane 🎺

Renin inhibitors versus angiotensin receptor blockers for primary

https://www.cochranelibrary.com/.../14651858.CD012570.pub2